- Government funding will support 250 researcher positions across 85
pioneering research projects to further accelerate Ireland’s recovery
through innovation-
- Projects funded through the Department of Jobs, Enterprise and Innovation
via Science Foundation Ireland over a wide range of disciplines e.g.
· applied mathematical modelling for industry and engineering;
· research into new anti-viral strategies to combat Hepatitis C; and
· computer-assisted neurosurgery.
The Minister for Jobs, Enterprise and Innovation, Richard Bruton TD and the
Minister for Research and Innovation, Sean Sherlock TD, today (Friday,
January 25th 2013) announced funding, totalling €60million, dedicated to 85
pioneering research initiatives. Administered via Science Foundation
Ireland’s (SFI) Investigator Programme, the 85 research projects will
directly support 250 researchers through to 2018. In time this investment
will also indirectly support further research initiatives and many more
researchers by leveraging significant additional funding from other sources
including competitive European research calls.
The top-class projects focus on a range of national research priority areas
identified by Government as key for developing new commercial products and
services from scientific research, including ICT, health/life sciences,
energy and manufacturing competitiveness. The projects being funded have
links to 36 companies thus far and the potential for creating jobs is a
critical factor.
Making the announcement, Minister Bruton said:
“A central part of this Government’s plan for jobs and growth is to
ensure that this research is better targeted at turning the good ideas
of researchers into good products and good jobs. That is why we have
implemented a series of reforming measures as part of Action Plan for
Jobs 2012, including
· Research Prioritisation – investing public money in those areas
that are most likely to yield commercial success and grow Jobs.
· A one-stop-shop for commercialising research – through a new
Technology Transfer Centre
· New research centres - funding centres of scale and excellence
which will forge alliances between industry and research together.
Today’s announcement that Government is investing a further €60million
in 85 new research projects supporting 250 researchers will build on
Ireland’s existing research strengths. Approximately 50% of IDA’s
company announcements last year had links with Science Foundation
Ireland funded researchers. By supporting these world-class researchers
in their ground-breaking work we will ensure that we continue to
maintain, attract and develop dynamic companies and create the quality
jobs we need.”
Speaking of the SFI Investigator announcement Minister for Research and
Innovation Sean Sherlock said,
“Over the past decade, Ireland has invested heavily in R&D and the
rewards are clearly visible. What is particularly heartening about
today’s announcement is that much of this excellent research, which
was selected competitively following international peer review, is
being done in collaboration with companies who are seeking to find
new products and services, including IBM Ireland, Intel Ireland, HP,
EMC and Bord Gáis.
I want to strongly commend SFI on leading on delivery of Government’s
Research Prioritisation objectives. I have no doubt that today’s
Investigators awards announcement of the over 80 oriented basic
research projects will deliver real economic and societal impacts for
Ireland.
Today is yet another visible signal regarding delivery of
Government’s Research Prioritisation objectives. I want to
congratulate the successful recipients across a diversity of
scientific disciplines who have stepped up to the mark and
demonstrated the relevance of their research excellence to our
enterprise and societal development. It shows that important
disciplines such as mathematics have a vital role to play and that
Research Prioritisation does not exclude them.”
The individual research projects funded, range in size and scale from
approximately €200,000 to €2.7milllion over the next 5 years and cover a
broad range of scientific topics including:
· Computer-assisted neurosurgery
· Animation
· Inflammatory diseases
· Mathematics for enterprise, science and technology
· Hepatitis C
· Advanced materials and manufacturing
· ICT
· Tissue engineering
· Chemistry
· Biofilms
· Microbiology
· Carbon sequestration
· Farm waste for Bioenergy
· Genetics
· Disease susceptibility & treatment
· Algae & seaweed
SFIs Investigator Programme is designed to support the development of world
class research and human capital in the areas of science, engineering and
mathematics that demonstrably support and underpin enterprise
competitiveness and societal development in Ireland.
Professor Mark Ferguson, Director General of SFI, said,
“These 85 funded research projects were selected from 419
applications following rigorous competitive peer review and ranking
by eminent international scientists. This 20% success rate is
comparable to international funding success rates for example that of
the National Institutes of Health, USA at 18%.”
The investigations cover a broad range of topics including:
mathematical modelling of complex industrial, engineering and
scientific problems, understanding, treating and potentially
preventing diseases such as diabetes, hepatitis C, cancer, cystic
fibrosis, inflammatory disorders, to next generation communications
systems, to advanced novel manufacturing technologies, to space
science detecting gamma-ray busts using novel instruments built by
Irish based companies which are also applicable in medical imaging.
Each project has great potential to impact positively on Ireland’s
future: both economically and societally.”
The SFI Investigator Programme 2012 call comprised two streams: projects
and awards, the main difference between them being the size and scale of
the awards. This year the two streams are merged and a separate programme
(SIRG – the Starting Investigator Research Grant) expanded to accept
applications from young talented researchers.
A follow up 2013 SFI Investigator Programme will be launched next week, on
29th January 2013 which will include an open call and a thematic call
funded jointly between SFI and Teagasc, entitled “Future Agri-Foods”.
ENDS
For further information or media queries please contact:
Aidan McLaughlin, Fleishman-Hillard, 085 749 0484 or
aidan.mclaughlin@fleishmaneurope.com
Alva O’Cleirigh, SFI, 087 915 2553 or alva.ocleirigh@sfi.ie
Roisin McCann, Dept of Jobs, Enterprise and Innovation 087 2594144
Notes to Editors:
Under the SFI Investigator Programme (2012 call) - 85 research projects are
being funded through 13 Research Bodies as follows:
Trinity College Dublin (29), University College Dublin (14), NUI Galway
(11), University College Cork (9); NUI Maynooth (5), Tyndall National
Institute (3), University of Limerick (3), Royal College of Surgeons of
Ireland (3) Dublin City University (3), Institute Technology Tallaght (2),
Dublin Institute Technology (1), Institute Technology Sligo (1), and Dublin
Institute for Advanced Studies (1).
The 85 awards are a combination of 33 large-scale Investigator (IvP) Awards
over 5 years (€46.4m in total at an average award value of €1.4m each) and
52 smaller Investigator projects over 3 years (€14.4m in total at an
average award value of €270k each).
|--------------------------------------------------+----------+------------|
| | | |
|--------------------------------------------------+----------+------------|
Some examples of Investigator Awards and Projects being funded :
Professor Stephen O’Brien, University of Limerick
Applied mathematical modelling applied to enterprise, science and
technology (MACSI)
Mathematics is the invisible glue which binds our technology together.
Mathematics is involved with most technologies: Weather prediction, climate
change, flood prevention; electricity, water supply, sewage treatment;
roads, buildings; airline scheduling, supermarket restocking. The award
continues the development of the Mathematics Applications Consortium for
Science and Industry (MACSI), a collaboration of Irish mathematicians and
enterprise partners, which foster new collaborative research, in particular
on problems that arise in industry.
Mathematical modellers perceive themselves as being scientists as well as
mathematicians and are interested in other disciplines apart from
mathematics. Without this philosophy, most modern technology would not
exist: airplanes would not fly, man would not have reached the moon, and
there would be no radar imaging nor scientific weather forecasts. Modern
mathematical models help to quantitatively explain how ultrasound works,
how diseases spread, how bubbles move in a pint of stout, how quickly spilt
fuel on an airport runway percolates through the underlying soil, how wet
paint drips from a ceiling, how the prices of options change. There are
even mathematical models for the dynamics of marriage.
Professor Cliona O’Farrelly, Trinity College Dublin
Is Natural Resistance to Hepatitis C in an Irish Cohort Associated with
JAK/STAT Resistance to HCV Targeting? Towards New Anti-Viral Strategies
The Hepatitis C Virus (HCV) blocks the function of the body’s immune cells
responsible for destroying the virus. We have discovered one way that the
virus is able to do this. There is a genetic variation in individuals, who
are naturally resistant to Hepatitis C infection that protects them from
the blocking effects of the virus. Working with Irish women who received
Hepatitis C contaminated injections but resisted infection, we aim to
identify the specific features of their immune systems responsible for
avoiding Hepatitis C infection. Understanding how the “super” immune
systems of these women naturally resist Hepatitis C has the potential to
reproduce this beneficial effect in new vaccines and therapies.
Professor Michael Gilchrist, University College Dublin
Characterising Mechanical Properties of Brain Tissue using Novel Micro
Indentation Tests
This project is relevant for future advance in the area of
computer-assisted neurosurgery. It has implications for the designing of
devices that can substitute motor, sensory or cognitive impairments and
help develop better neurosurgical instruments. It is also relevant for the
engineering and design of accident investigation reconstructions. Current
work in this area is based on assuming that the make-up of brain tissue is
identical across both the grey matter, containing the cell bodies of the
brain, and the white matter, containing the nerves. In fact, this is not
the case. This project aims to develop novel test procedures that will
characterise these differences in brain tissue across time, and will
provide new data that will be accurate at very small scales down to the
millimetre.
Dr. Emma Creagh, Trinity College Dublin
Identification & Functional Characterisation of Novel Inflammatory
Mediators
Inflammation is the body’s primary response to infection and injury. This
project focuses on an important inflammatory activator which can switch on
inflammation. In some cases the hyper-activation of this inflammatory
activator can lead to inappropriate activation of inflammation, resulting
in many of the inflammatory diseases that exist today. Our preliminary
results have revealed new proteins that bind to this inflammatory activator
and have the potential to switch it on or off. The research objective is
to confirm these novel binding proteins and identify their role during
inflammation. Understanding how our body controls the switching-on and off
of inflammatory activators is critical to developing new treatments and
drugs to alleviate the symptoms of inflammatory disease.
List of Awardees
First | Surname | Researc | Research Title | Total Award*
Name | | h Body | |
-----------+-------------+----------+-----------------------------+-------------------
John | Atkins | (UCC) | Using ribosome profiling | 381,032
| | | to study translation |
| | | initiation/elongation and |
| | | facilitate optimization of |
| | | protein synthesis |
-----------+-------------+----------+-----------------------------+-------------------
Pavel | Baranov | (UCC) | Development of | 1,616,824
| | | computational resources |
| | | for the analysis of Genome |
| | | Wide Information on |
| | | Protein Synthesis (GWIPS). |
-----------+-------------+----------+-----------------------------+-------------------
Werner | Blau | (TCD) | Systematic Bottom-Up | 597,214
| | | Assembly of Nanocarbon |
| | | Based Photonic Materials |
-----------+-------------+----------+-----------------------------+-------------------
John | Boland | (TCD) | Atom Level Engineering of | 2,481,498
| | | Material-on-Insulator |
| | | Devices and Sensors |
-----------+-------------+----------+-----------------------------+-------------------
Dermot | Brabazon | (DCU) | Laser processing for | 814,992
| | | fabrication of advanced |
| | | liquid chromatographic |
| | | systems |
-----------+-------------+----------+-----------------------------+-------------------
Thomas | Brazil | (UCD) | Green Power Amplifier | 984,565
| | | Technologies for Future |
| | | Wideband Reconfigurable |
| | | Wireless Communication |
| | | Systems (GrePATech) |
-----------+-------------+----------+-----------------------------+-------------------
Dermot | Brougham | (DCU) | Long-circulating Magnetic | 199,000
| | | Nanoparticles for |
| | | Biomedical Applications |
| | | through Mimetic Surface |
| | | Chemistry |
-----------+-------------+----------+-----------------------------+-------------------
Jim | Buckley | (UL) | Establishing best practice | 276,377
| | | in Software Architecture |
| | | Consistency Processes |
-----------+-------------+----------+-----------------------------+-------------------
Miguel | Bustamante | (UCD) | Genesis and Development of | 285,211
| | | Extreme Events in Fluids |
-----------+-------------+----------+-----------------------------+-------------------
Geraldin | Butler | (UCD) | Post-genomic analysis of | 1,362,601
e | | | biofilm and virulence |
| | | characteristics of the |
| | | pathogenic yeast, Candida |
| | | parapsilosis. |
-----------+-------------+----------+-----------------------------+-------------------
Martin | Caffrey | (TCD) | Membrane Structural and | 2,478,511
| | | Functional Biology. |
| | | Tackling communicable and |
| | | non-communicable diseases |
| | | at the membrane level. |
-----------+-------------+----------+-----------------------------+-------------------
Jens | Carlsson | (UCC) | Taxonomy and connectivity | 194,498
| | | of animal species at the |
| | | Moytirra hydrothermal vent |
| | | field: developing methods |
| | | for assessing ecological |
| | | impacts of mineral |
| | | extraction in the deep-sea |
| | | |
-----------+-------------+----------+-----------------------------+-------------------
Gianpier | Cavalleri | (RCSI) | The identification and | 381,150
o | | | characterisation of |
| | | genomic signatures of |
| | | hypoxia induced natural |
| | | selection |
-----------+-------------+----------+-----------------------------+-------------------
David | Chew | (TCD) | Microanalysis of detrital | 279,826
| | | apatite: a new provenance |
| | | proxy in sedimentary |
| | | systems |
-----------+-------------+----------+-----------------------------+-------------------
David | Clarke | (UCC) | Characterizaton of choA, a | 244,360
| | | gene encoding a novel |
| | | cholesterol-degrading |
| | | activity in the human gut |
| | | microbiome |
-----------+-------------+----------+-----------------------------+-------------------
Paula | Colavita | (TCD) | Understanding lipid/carbon | 306,216
| | | interactions for the |
| | | rational design of |
| | | biomaterials |
-----------+-------------+----------+-----------------------------+-------------------
Stephen | Connon | (TCD) | Anhydrides as nucleophiles | 1,404,834
| | | in new catalytic |
| | | asymmetric processes: |
| | | development, scope |
| | | expansion and application |
| | | in drug development |
-----------+-------------+----------+-----------------------------+-------------------
John | Costello | (DCU) | Stagnation Layers in Laser | 816,950
| | | Ablation Based Analytical |
| | | Techniques |
-----------+-------------+----------+-----------------------------+-------------------
Emma | Creagh | (TCD) | Identification & | 210,169
| | | Functional |
| | | Characterisation of Novel |
| | | Inflammatory Mediators. |
-----------+-------------+----------+-----------------------------+-------------------
Bernie | Creaven | (ITT) | Novel Dual SOD/CAT mimics: | 203,300
| | | New Therapeutic Strategy |
| | | for Oxidative Stress |
| | | Related Diseases? |
-----------+-------------+----------+-----------------------------+-------------------
Kenneth | Dawson | (UCD) | Biological Identity of | 1,758,794
| | | Nanoparticles Dispersed in |
| | | Biological Media |
-----------+-------------+----------+-----------------------------+-------------------
Eithne | Dempsey | (ITT) | Implementation of Gold | 353,600
| | | Quantitation |
| | | Immuno-Electrochemistry |
| | | (AURO-QUANT) |
-----------+-------------+----------+-----------------------------+-------------------
Kevin | Devine | (TCD) | Cell wall metabolism in | 1,240,385
| | | Gram positive bacteria: |
| | | investigating its |
| | | regulation and exploiting |
| | | its therapeutic potential. |
-----------+-------------+----------+-----------------------------+-------------------
Gary | Donohoe | (TCD) | Characterising the neural | 284,650
| | | basis of social cognition |
| | | deficits in schizophrenia |
| | | using imaging genetics |
-----------+-------------+----------+-----------------------------+-------------------
Sean | Doyle | (NUIM) | A Vaccination Strategy | 358,497
| | | Against Aspergillus |
| | | fumigatus Infection. |
-----------+-------------+----------+-----------------------------+-------------------
Ken | Duffy | (NUIM) | Quantitative analysis of | 228,820
| | | immune cell fate: |
| | | stochastic competition and |
| | | censorship |
-----------+-------------+----------+-----------------------------+-------------------
Laurence | Egan | (NUIG) | Molecular Regulation of | 281,760
| | | the Tumor Microenvironment |
| | | in Colon Cancer Metastasis |
-----------+-------------+----------+-----------------------------+-------------------
Rachel | Evans | (TCD) | High-Efficiency Conjugated | 325,371
| | | Polymer-Inorganic Hybrids |
| | | as Luminescent Solar |
| | | Concentrators for |
| | | Photovoltaics |
-----------+-------------+----------+-----------------------------+-------------------
Stephen | Fahy | (TNI) | Ultrafast energy | 1,299,545
| | | dissipation in semimetals |
| | | and semiconductors: |
| | | Simulation based on |
| | | first-principles |
| | | electronic structure |
| | | theory |
-----------+-------------+----------+-----------------------------+-------------------
Mario | Fares | (TCD) | Understanding the role of | 371,358
| | | molecular chaperones in |
| | | robustness and functional |
| | | innovation |
-----------+-------------+----------+-----------------------------+-------------------
David | Finlay | (TCD) | Characterising the role of | 261,606
| | | mammalian Target Of |
| | | Rapamcyin Complex 1 |
| | | (mTORC1)/Srebp1c signaling |
| | | in directing the |
| | | differentiation and |
| | | function of T cell |
| | | subsets. |
-----------+-------------+----------+-----------------------------+-------------------
Garry | Fleming | (TCD) | DENTAL glass-ionomer | 309,617
| | | restoratives: Development |
| | | of an Enhanced Novel |
| | | Tailored Aesthetic Ligand |
| | | based glass-ionomer |
| | | restorative |
-----------+-------------+----------+-----------------------------+-------------------
Nial | Friel | (UCD) | Advances for the | 289,240
| | | probabilistic analysis of |
| | | network data |
-----------+-------------+----------+-----------------------------+-------------------
Michael | Gilchrist | (UCD) | Characterising Mechanical | 315,007
| | | Properties of Brain Tissue |
| | | using Novel Micro |
| | | Indentation Tests |
-----------+-------------+----------+-----------------------------+-------------------
Martin | Glavin | (NUIG) | Breast Cancer detection | 243,900
| | | and classification using |
| | | Ultra Wideband Radar |
| | | Tomography |
-----------+-------------+----------+-----------------------------+-------------------
David | Gregg | (TCD) | Data-centric ultra-low | 563,120
| | | power embedded computing |
-----------+-------------+----------+-----------------------------+-------------------
Darren | Griffith | (RCSI) | Novel Strategy for | 192,029
| | | Overcoming Chemoresistance |
| | | and Toxicity Associated |
| | | with Platinum Anti-cancer |
| | | Compounds |
-----------+-------------+----------+-----------------------------+-------------------
Yurii | Gun'ko | (TCD) | Chiral inorganic | 808,460
| | | nanomaterials |
-----------+-------------+----------+-----------------------------+-------------------
Anne | Healy | (TCD) | Co-processing of active | 188,919
Marie | | | pharmaceutical ingredients |
| | | with functional excipients |
| | | to prevent unintentional |
| | | generation of amorphous |
| | | phase |
-----------+-------------+----------+-----------------------------+-------------------
Mary | Heaney | (NUIM) | "Clickable" Azobenzenes, | 215,339
Frances | | | New Molecular Glues for |
| | | Generation of |
| | | Photoresponsive |
| | | Biomolecular Scaffolds |
| | | capable of Answering |
| | | Biological Questions |
-----------+-------------+----------+-----------------------------+------------------- Katherin | Howell | (UCD) | Elucidating the the | 348,343
e | | | potential therapuetic role |
| | | of Erythropoietin in the |
| | | treatment of Emphysema |
-----------+-------------+----------+-----------------------------+-------------------
Suzi | Jarvis | (UCD) | Nanoscale | 1,233,925
| | | aqueous-substrate |
| | | interfaces |
-----------+-------------+----------+-----------------------------+-------------------
Leigh | Jones | (NUIG) | The Strategic Construction | 179,675
| | | of Magnetic Coolant |
| | | Materials |
-----------+-------------+----------+-----------------------------+-------------------
Alan | Jones | (DIAS) | IRECCSEM: Evaluating | 278,616
| | | Ireland's potential for |
| | | onshore carbon |
| | | sequestration and storage |
| | | using electromagnetics |
-----------+-------------+----------+-----------------------------+-------------------
Daniel J | Kelly | (TCD) | A tissue engineered | 1,715,936
| | | biological joint |
| | | replacement prosthesis for |
| | | the treatment of |
| | | degenerative joint disease |
-----------+-------------+----------+-----------------------------+-------------------
Amir | Khan | (TCD) | Molecular Aspects of | 1,204,672
| | | Immune Evasion and |
| | | Subversion of Membrane |
| | | Trafficking by Pathogens |
-----------+-------------+----------+-----------------------------+-------------------
Vojislav | Krstic | (TCD) | Next-generation III-V | 362,475
| | | Quasi-1D Nanowires for |
| | | Advanced Future |
| | | Information-Processing |
| | | Circuitry |
-----------+-------------+----------+-----------------------------+-------------------
Ed | Lavelle | (TCD) | Modulation of innate and | 1,797,268
| | | adaptive immunity by |
| | | particulate adjuvants for |
| | | improved parenteral and |
| | | mucosal vaccination |
-----------+-------------+----------+-----------------------------+-------------------
James | Lunney | (TCD) | Pulsed laser deposition of | 252,595
| | | thin films at atmospheric |
| | | pressure |
-----------+-------------+----------+-----------------------------+-------------------
Fiona | Lyng | (DIT) | Identification of | 193,700
| | | clinically important, high |
| | | risk oral lesions using |
| | | Raman spectroscopy |
-----------+-------------+----------+-----------------------------+-------------------
Sheila | McBreen | (UCD) | Advances in gamma-ray | 247,382
| | | Space Science using |
| | | Silicon Photomultipliers |
-----------+-------------+----------+-----------------------------+-------------------
Rachel | McDonnell | (TCD) | Cartoon Motion: Stylised | 272,270
| | | facial animation from |
| | | motion capture |
-----------+-------------+----------+-----------------------------+-------------------
Patrick | McGarry | (NUIG) | Active changes in artery | 226,094
| | | structure and |
| | | contractility in response |
| | | to stenting |
-----------+-------------+----------+-----------------------------+-------------------
Gerard | McGlacken | (UCC) | The Direct Arylation of | 377,092
| | | Pyrones, Coumarins, |
| | | Pyridones and Quinolones |
-----------+-------------+----------+-----------------------------+-------------------
John | McInerney | (UCC) | Pulsed semiconductor | 205,270
| | | lasers for metrology and |
| | | remote sensing: |
| | | synchronisation and |
| | | stabilisation dynamics |
-----------+-------------+----------+-----------------------------+-------------------
Paul | McLoughlin | (UCD) | The role of the bone | 1,308,097
| | | morphogenetic antagonist |
| | | gremlin in the |
| | | pathogenesis of chronic |
| | | hypoxic lung disease |
-----------+-------------+----------+-----------------------------+-------------------
Rachel | McLoughlin | (TCD) | Understanding cellular | 384,042
| | | immunity to Staphylococcus |
| | | aureus is required for |
| | | novel anti-S. aureus |
| | | vaccine design |
-----------+-------------+----------+-----------------------------+-------------------
Tara | McMorrow | (UCD) | Molecular mechanisms of | 319,180
| | | cilia loss in mammalian |
| | | epithelial cells |
-----------+-------------+----------+-----------------------------+-------------------
Grace | Morgan | (UCD) | Nano-Assembly of | 320,651
| | | Functional Magnetic and |
| | | Magneto-Optical Materials |
-----------+-------------+----------+-----------------------------+-------------------
Derek | Morris | (TCD) | Gene discovery in | 355,395
| | | schizophrenia using |
| | | family-based sequencing |
| | | methods |
-----------+-------------+----------+-----------------------------+-------------------
Paul | Moynagh | (NUIM) | Defining the roles and | 2,042,513
| | | mechanisms of action of |
| | | Pellino proteins in |
| | | immunity and inflammatory |
| | | diseases |
-----------+-------------+----------+-----------------------------+-------------------
Paul | Murphy | (NUIG) | Glycoside & glycoconjugate | 1,009,646
| | | synthesis through |
| | | development and |
| | | application of chelation |
| | | induced anomerization |
-----------+-------------+----------+-----------------------------+-------------------
Yvonne | Nolan | (UCC) | The nuclear receptor TLX | 1,082,494
| | | as a cell intrinsic |
| | | regulator underlying |
| | | inflammation and |
| | | stress-induced changes in |
| | | hippocampal neurogenesis: |
| | | relevance to cognitive |
| | | disorders |
-----------+-------------+----------+-----------------------------+-------------------
Stephen | O'Brien | (UL) | Applied mathematical | 2,759,414
| | | modelling applied to |
| | | enterprise, science and |
| | | technology (MACSI) |
-----------+-------------+----------+-----------------------------+-------------------
David | O'Connell | (UCD) | Novel affinity matrices | 262,288
| | | for purification of |
| | | biotherapeutics |
-----------+-------------+----------+-----------------------------+-------------------
Cliona | O'Farrelly | (TCD) | Is Natural Resistance to | 1,742,265
| | | Hepatitis C in an Irish |
| | | Cohort Associated with |
| | | JAK/STAT Resistance to HCV |
| | | Targeting? Towards New |
| | | Anti-Viral Strategies |
-----------+-------------+----------+-----------------------------+-------------------
Luke | O'Neill | (TCD) | Novel regulators of the | 2,385,259
| | | Nlrp3 inflammasome and |
| | | IL-1beta: prospects for |
| | | novel therpeutics and |
| | | diagnostics for |
| | | inflammatory diseases |
-----------+-------------+----------+-----------------------------+-------------------
Mani | Ramaswami | (TCD) | Translational control of | 1,430,253
| | | neuronal mRNAs: its |
| | | mechanisms, and roles in |
| | | memory and |
| | | neurodegeneration. |
-----------+-------------+----------+-----------------------------+-------------------
Fernando | Rhen | (UL) | Nanostructured alloy for | 174,880
| | | high-energy-efficient fuel |
| | | cells |
-----------+-------------+----------+-----------------------------+-------------------
James | Rice | (UCD) | Patterned nanomaterial’s | 241,175
| | | using ferroelectric |
| | | lithography for enhanced |
| | | optical imaging |
-----------+-------------+----------+-----------------------------+-------------------
Thomas | Ritter | (NUIG) | Novel therapeutic | 1,303,013
| | | approaches to improve |
| | | corneal allograft survival |
| | | by cell and gene therapy |
| | | and insights into the |
| | | mechanism of action |
-----------+-------------+----------+-----------------------------+-------------------
James | Rohan | (TNI) | Nanomaterials design and | 241,926
| | | fabrication for Energy |
| | | Storage |
-----------+-------------+----------+-----------------------------+-------------------
Robert | Ryan | (UCC) | Elucidation of the | 282,352
| | | regulatory role of |
| | | bacterial cell-cell |
| | | signalling in persistent |
| | | infection of the cystic |
| | | fibrosis lung by |
| | | Burkholderia cenocepacia |
-----------+-------------+----------+-----------------------------+-------------------
Corrado | Santocanal | (NUIG) | Cdc7 regulation of Claspin | 292,484
| e | | stability and its effect |
| | | on cell cycle checkpoint |
| | | function |
-----------+-------------+----------+-----------------------------+-------------------
Igor | Shvets | (TCD) | Science of p-type | 1,924,402
| | | transparent conducting |
| | | oxides: materials towards |
| | | transparent electronics |
-----------+-------------+----------+-----------------------------+-------------------
Johannes | Slingerlan | (NUIM) | Topological Order and | 719,693
Klaas | d | | Fault Tolerant Quantum |
| | | Computation |
-----------+-------------+----------+-----------------------------+-------------------
Dagmar | Stengel | (NUIG) | Iodine in commercially | 244,782
| | | valuable Irish seaweeds: |
| | | variability, pathways, and |
| | | implications for |
| | | industrial applications |
-----------+-------------+----------+-----------------------------+-------------------
Nathan | Stevenson | (UCC) | Automated assessment of | 145,697
| | | brain maturation in the |
| | | preterm infant using EEG |
-----------+-------------+----------+-----------------------------+-------------------
Kevin | Sullivan | (NUIG) | Structure and assembly of | 387,900
| | | vertebrate |
| | | kinetochore-associated |
| | | chromatin |
-----------+-------------+----------+-----------------------------+-------------------
Nicolas | Touzet | (ITS) | Physiology and molecular | 379,845
| | | biology of microalgae for |
| | | the biorefining of |
| | | valuable metabolites |
-----------+-------------+----------+-----------------------------+-------------------
Paul | Townsend | (TNI) | Next Generation Photonic | 2,570,493
| | | Access and Data |
| | | Communication Systems |
-----------+-------------+----------+-----------------------------+-------------------
Wenxin | Wang | (NUIG) | Development and Delivery | 267,291
| | | of Nonviral S/MAR |
| | | Minicircles for Long-term |
| | | Type VII Collagen Gene |
| | | expression for the |
| | | Treatment of Recessive |
| | | Dystrophic Epidermolysis |
| | | Bullosa |
-----------+-------------+----------+-----------------------------+-------------------
Graeme | Watson | (TCD) | Understanding the role of | 905,910
| | | interfaces in solid oxide |
| | | fuel cell efficiency: |
| | | Optimising materials |
| | | through predictive |
| | | computer simulation |
-----------+-------------+----------+-----------------------------+-------------------
Leonie | Young | (RCSI) | SRC-1 mediation of cancer | 681,543
| | | cell reprogramming in |
| | | endocrine resistant breast |
| | | cancer |
-----------+-------------+----------+-----------------------------+-------------------
Xinmin | Zhan | (NUIG) | Green Farm: Development of | 361,010
| | | On-Farm Co-Digestion of |
| | | the Organic Fraction of |
| | | Municipal Solid Waste and |
| | | Animal Manure for |
| | | Bioenergy Production and |
| | | Resource Recycling |
*Subject to final agreement with Awardee/Research Body; inclusive of
approx. 30% overhead payment to Research Body